Trial of swine influenza vaccine in healthy adults
Phase 1
Completed
- Conditions
- Swine influenzaInfection - Other infectious diseases
- Registration Number
- ACTRN12609000674235
- Lead Sponsor
- Vaxine Pty Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Healthy adults
Exclusion Criteria
Pregnancy
Lactation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Seroconversion to 2009 H1N1 as assessed by haemagglutination inhibition assay[3 weeks post first and second vaccination]
- Secondary Outcome Measures
Name Time Method Safety as assessed by frequency of vaccine-related and total adverse events[3 weeks post first and second vaccination];Anti-swine flu T-cell responses as assessed by T-cell recall responses[3 weeks post first and second vaccination];Vaccine tolerability as assessed by visual analogue pain score[At time of administration of first and second vaccination]